BCMA expression was assessed in two studies of acute B-lymphoblastic leukemia (B-ALL), two studies that investigated both T-ALL and B-ALL, and one acute myeloid leukemia (AML) study. Here, TNFRSF17 is linked to precursor B-cell acute lymphoblastic leukemia.